BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao H, Wang Y, Luan N, Liu C. Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice. Vaccines (Basel) 2021;9:310. [PMID: 33805880 DOI: 10.3390/vaccines9040310] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Yang J, Sun R, Han S, Yang Z, Teng L. Microfluidics for nano-drug delivery systems: From fundamentals to industrialization. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.01.018] [Reference Citation Analysis]
2 Liu J, Lin J, Cai L, Sun J, Ding X, Wang C, Wu Y, Gao X, Su W, Jiang C. Immunogenicity of Varicella Zoster Virus DNA Vaccines Encoding Glycoprotein E and Immediate Early Protein 63 in Mice. Viruses 2022;14:1214. [DOI: 10.3390/v14061214] [Reference Citation Analysis]
3 Luan N, Li T, Wang Y, Cao H, Yin X, Lin K, Liu C. Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro. Front Immunol 2022;13:882856. [PMID: 35464483 DOI: 10.3389/fimmu.2022.882856] [Reference Citation Analysis]
4 Tabarzad M, Mohit E, Ghorbani-bidkorbeh F. Nanovaccines delivery approaches against infectious diseases. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 2022. [DOI: 10.1016/b978-0-323-90792-7.00002-6] [Reference Citation Analysis]
5 Cao H, Wang Y, Luan N, Lin K, Liu C. Effects of Varicella-Zoster Virus Glycoprotein E Carboxyl-Terminal Mutation on mRNA Vaccine Efficacy. Vaccines (Basel) 2021;9:1440. [PMID: 34960186 DOI: 10.3390/vaccines9121440] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cao H, Yang S, Wang Y, Luan N, Yin X, Lin K, Liu C. An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit Vaccine Is Not Reversible by Sequential Immunization with Nucleic Acid-Adjuvanted Th1-Oriented Subunit Vaccines. Vaccines (Basel) 2021;9:1261. [PMID: 34835192 DOI: 10.3390/vaccines9111261] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Wilson HL, Haddadi A, Mutwiri GK. Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action. Vaccines (Basel) 2021;9:667. [PMID: 34207033 DOI: 10.3390/vaccines9060667] [Reference Citation Analysis]